DDRE-33. MELATONIN AS A MASTER METABOLIC SWITCH FOR GLIOBLASTOMA

Glioblastoma (GBM) is the most common form of malignant primary brain cancer in adults with a median survival of only 15 months. Therefore, new therapies to suppress malignant brain cancer are needed. Brain Tumor Initiating Cells (BTICs) are a GBM subpopulation of cells with a highly glycolytic prof...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandez-Gil, Beatriz Irene, Vazquez-Ramos, Carla, Bechtle, Alexandra, Suarez-Meade, Paola, Qosja, Neda, Schiapparelli, Paula, Sarabia-Estrada, Rachel, Escames, Germaine, Quinones-Hinojosa, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992251/
http://dx.doi.org/10.1093/noajnl/vdab024.055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992251/
http://dx.doi.org/10.1093/noajnl/vdab024.055

Ejemplares similares